SK Biopharmaceuticals Co., Ltd. (KRX:326030)
South Korea flag South Korea · Delayed Price · Currency is KRW
105,600
+500 (0.48%)
Mar 12, 2025, 9:00 AM KST

SK Biopharmaceuticals Market Cap

SK Biopharmaceuticals has a market cap or net worth of 8.26 trillion as of March 12, 2025. Its market cap has increased by 23.83% in one year.

Market Cap
8.26T
Enterprise Value
8.20T
Revenue
511.33B
Ranking
n/a
PE Ratio
143.98
Stock Price
105,600.00

Market Cap Chart

Since July 2, 2020, SK Biopharmaceuticals's market cap has decreased from 9.95T to 8.26T, a decrease of -16.93%. That is a compound annual growth rate of -3.87%.

History

DateMarket Cap% Change
Mar 11, 20258,230.72B-5.40%
Dec 30, 20248,700.60B10.66%
Dec 28, 20237,862.65B39.25%
Dec 29, 20225,646.39B-25.82%
Dec 30, 20217,612.05B-42.49%
Dec 30, 202013.23T33.07%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition